Zobrazeno 1 - 10
of 4 503
pro vyhledávání: '"Pagani, O"'
Autor:
Pagan E; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy., Ruggeri M; Program for Young Patients, International Breast Cancer Study Group, a Division of ETOP IBCSG Partners Foundation, Bern, Switzerland., Bianco N; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Bucci EO; Breast Cancer Unit, Ospedale MultiMedica, Castellanza, VA, Italy., Graffeo R; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Borner M; Division of Oncology (Oncocare), Klinik Engeried, Lindenhofgruppe, Bern, Switzerland., Giordano M; ASST-Lariana, Como, Italy., Gianni L; Department of Medical Oncology, Ospedale Infermi, Rimini, AUSL Della Romagna, Italy., Rabaglio M; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Freschi A; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081, Aviano, Italy., Cretella E; Department of Medical Oncology, Azienda Sanitaria Dell'Alto Adige, Bolzano, Italy., Seles E; Department of Medical Oncology, Ospedale Degli Infermi, Biella, Italy., Farolfi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Simoncini E; Breast Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Ciccarese M; Regional Agency for Social and Health Development (AReSS Puglia), Bari, Italy., Rauch D; Onko-Netz, Thun, Switzerland., Favaretto A; Medical Oncology Unit, Azienda ULSS2, Marca Trevigiana, Treviso, Italy., Honecker F; Tumor- and Breast Eastern Switzerland, St. Gallen, Switzerland., Berardi R; Department of Medical Oncology, Università Politecnica Delle Marche, A.O.U. Delle Marche, Ancona, Italy., Franzetti-Pellanda A; Radiotherapy Service, Gruppo Ospedaliero Moncucco, Clinica Moncucco, Lugano, Switzerland., Gelber S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Goldhirsch A; International Breast Cancer Study Group, IEO European Institute of Oncology, IRCCS, Milan, Italy., Bagnardi V; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy., Pagani O; Geneva University Hospitals, Lugano University, Swiss Group for Clinical Cancer Research (SAKK), Switzerland., Ribi K; Quality of Life Office, International Breast Cancer Study Group, a division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Careum School of Health, Part of the Kalaidos University of Applied Sciences, Zurich, Switzerland. Electronic address: karin.ribi@etop.ibcsg.org.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2024 Oct; Vol. 77, pp. 103765. Date of Electronic Publication: 2024 Jul 04.
Autor:
Azim HA Jr; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Niman SM; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Partridge AH; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Demeestere I; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Ruggeri M; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gelber RD; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Pagani O; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy., Peccatori FA; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 16, pp. JCO2401683. Date of Electronic Publication: 2024 Sep 16.
Autor:
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M.S., André, F., Barrios, C.H., Bergh, J., Bhattacharyya, G.S., Biganzoli, L., Boyle, F., Cardoso, M.-J., Carey, L.A., Cortés, J., El Saghir, N.S., Elzayat, M., Eniu, A., Fallowfield, L., Francis, P.A., Gelmon, K., Gligorov, J., Haidinger, R., Harbeck, N., Hu, X., Kaufman, B., Kaur, R., Kiely, B.E., Kim, S.-B., Lin, N.U., Mertz, S.A., Neciosup, S., Offersen, B.V., Ohno, S., Pagani, O., Prat, A., Penault-Llorca, F., Rugo, H.S., Sledge, G.W., Thomssen, C., Vorobiof, D.A., Wiseman, T., Xu, B., Norton, L., Costa, A., Winer, E.P.
Publikováno v:
In Annals of Oncology December 2020 31(12):1623-1649
Autor:
Paluch-Shimon, S., Cardoso, F., Partridge, A.H., Abulkhair, O., Azim, H.A., Jr., Bianchi-Micheli, G., Cardoso, M.-J., Curigliano, G., Gelmon, K.A., Harbeck, N., Merschdorf, J., Poortmans, P., Pruneri, G., Senkus, E., Spanic, T., Stearns, V., Wengström, Y., Peccatori, F., Pagani, O.
Publikováno v:
In Annals of Oncology June 2020 31(6):674-696
Autor:
Ruggeri, M., Pagan, E., Bagnardi, V., Bianco, N., Gallerani, E., Buser, K., Giordano, M., Gianni, L., Rabaglio, M., Freschi, A., Cretella, E., Clerico, M., Farolfi, A., Simoncini, E., Ciccarese, M., Rauch, D., Ramello, M., Glaus, A., Berardi, R., Pellanda, A. Franzetti, Ribi, K., Gelber, S., Partridge, A.H., Goldhirsch, A., Pagani, O.
Publikováno v:
In The Breast October 2019 47:85-92
Autor:
Corona, S.P., Roviello, G., Strina, C., Milani, M., Madaro, S., Zanoni, D., Allevi, G., Aguggini, S., Cappelletti, M.R., Francaviglia, M., Azzini, C., Cocconi, A., Sirico, M., Bortul, M., Zanconati, F., Giudici, F., Rosellini, P., Meani, F., Pagani, O., Generali, D.
Publikováno v:
In The Breast August 2019 46:19-24
Autor:
Azim HA Jr; Cairo Cure Oncology Center, Cairo, Egypt.; Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Niman SM; International Breast Cancer Study Group Statistical Center, Boston, MA.; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Demeestere I; Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium.; Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium., Ruggeri M; Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Saura C; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Shimizu C; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan., Saetersdal AB; Breast Cancer Unit, Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Dutch Breast Cancer Research Group (BOOG), Amsterdam, the Netherlands., Mailliez A; Breast Cancer Unit, Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Warner E; Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada.; Canadian Clinical Trials Group (CCTG), Toronto, ON, Canada., Borges VF; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO., Amant F; Department of Oncology, KU Leuven and Leuven Cancer Institute, Leuven, Belgium.; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.; Antoni van Leeuwenhoek-Netherlands Gynecologic Oncology Cancer Institute, Amsterdam, the Netherlands., Gombos A; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium., Kataoka A; Breast Oncology Cancer, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Centre, Centre Léon Bérard, Lyon, France., Borstnar S; Division of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia., Takei J; St Luke's International Hospital, Breast Center, Tokyo, Japan., Lee JE; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Department of Clinical Research and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea., Walshe JM; Cancer Trials Ireland, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Tallaght University Hospital, Dublin, Ireland., Ruíz-Borrego M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Virgen del Rocio Sevilla, Sevilla, Spain., Moore HCF; Breast Oncology Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Saunders C; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Bjelic-Radisic V; Breast Unit, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany.; Medical University Graz, Department Gynaecology, Graz, Austria.; Austrian Breast and Colorectal Study Group (ABCSG), Vienna, Austria., Susnjar S; Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Klar NJ; New York University Langone's Perlmutter Cancer Center, Breast Cancer Center, New York, NY., Spanic T; Europa Donna, Ljubljana, Slovenia., Ruddy K; Department of Oncology, Mayo Clinic, Rochester, MN., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium., Korde LA; Breast and Melanoma Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Goldhirsch A; International Breast Cancer Study Group, Division of ETOP IBCSG Partners Foundation, Bern, Switzerland.; IEO, European Institute of Oncology, IRCCS, Milan, Italy., Gelber RD; International Breast Cancer Study Group Statistical Center, Boston, MA.; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Frontier Science Foundation, Boston, MA.; Harvard TH Chan School of Public Health, Boston, MA., Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Peccatori FA; Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 10; Vol. 42 (23), pp. 2822-2832. Date of Electronic Publication: 2024 May 29.
Autor:
Cardoso F; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, and ABC Global Alliance, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt., Paluch-Shimon S; Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel., Schumacher-Wulf E; Mamma Mia, Kronberg, Germany., Matos L; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal., Gelmon K; BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada., Aapro MS; Cancer Center, Clinique de Genolier, Genolier, Switzerland., Bajpai J; Tata Memorial Centre, HBNI, Mumbai, India., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil., Bergh J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Bergsten-Nordström E; Europa Donna - the European Breast Cancer Coalition, Norrkoping, Sweden., Biganzoli L; Department of Oncology, Hospital of Prato - Azienda USL Toscana Centro Prato, Italy and European Society of Breast Cancer Specialists (EUSOMA), Italy., Cardoso MJ; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation and Lisbon University, Faculty of Medicine, Lisbon, Portugal., Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Chavez-MacGregor M; Health Services Research, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA and American Society of Clinical Oncology (ASCO), Houston, USA., Chidebe R; Project PINKBLUE, Abuja, Nigeria., Cortés J; International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain., Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Dent RA; National Cancer Center Singapore, Singapore, Singapore., El Saghir NS; NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Eniu A; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland and European School of Oncology (ESO), United Kingdom., Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Brighton, United Kingdom., Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia., Franco Millan SX; CTIC, Cancer Treatment and Research Center, Bogotá, Colombia., Gilchrist J; Macquarie University, Sydney, Australia., Gligorov J; Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Nice/St Paul Guidelines, Paris, France., Gradishar WJ; Northwestern Medicine, Illinois, USA and National Comprehensive Cancer Network (NCCN), USA., Haidinger R; Brustkrebs Deutschland e.V., Munich, Germany., Harbeck N; Breast Centre, University of Munich, Munich and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Hu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Kaur R; Breast Cancer Welfare Association, Petaling Jaya, Malaysia., Kiely B; NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia., Kim SB; Asan Medical Centre, Department of Oncology, Seoul, South Korea., Koppikar S; Lilavati Hospital and Research Centre, Bombay Hospital Institute of Medical Sciences, Asian Cancer Institute, Mumbai, India., Kuper-Hommel MJJ; Te Whatu Ora Waikato, Midland Regional Cancer Centre, NZ ABC Guidelines, Hamilton, New Zealand., Lecouvet FE; Department of Radiology, Institut Roi Albert II and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Mason G; Inflammatory Breast Cancer Research Foundation, West Lafayette, USA., Mertz SA; MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, USA., Mueller V; University Medical Center Hamburg-Eppendorf, Hamburg and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Myerson C; Breast Cancer Now, London, United Kingdom., Neciosup S; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, ABC Latin America Guidelines, Peru., Offersen BV; Department of Oncology, Aarhus University Hospital, Aarhus, European Society for Radiotherapy and Oncology (ESTRO), Denmark., Ohno S; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan., Pagani O; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland., Partridge AH; Dana-Farber Cancer Institute, Department of Medical Oncology and Division of Breast Oncology, Boston, USA and American Society of Clinical Oncology (ASCO), USA., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000, Clermont Ferrand, Nice/St Paul Guidelines, France., Prat A; Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain., Rugo HS; Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland., Sledge GW; Division of Oncology, Stanford School of Medicine, Stanford, USA., Swain SM; Georgetown University Lombardi Comprehensive Cancer Center and MedStar Health, Washington DC, USA., Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale) and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Vorobiof DA; Belong.Life, New York, USA., Vuylsteke P; University of Botswana, Gaborone, Botswana and CHU UCL Namur Hospital, UCLouvain, Belgium., Wiseman T; The Royal Marsden NHS Foundation Trust, University of Southampton, United Kingdom and European Oncology Nursing Society (EONS), United Kingdom., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Costa A; European School of Oncology, Milan, Italy and Bellinzona, Switzerland., Norton L; Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, USA., Winer EP; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2024 Aug; Vol. 76, pp. 103756. Date of Electronic Publication: 2024 May 28.
Autor:
Gennari, A. *, Sun, Z., Hasler-Strub, U., Colleoni, M., Kennedy, M.J., Von Moos, R., Cortés, J., Vidal, M.J., Hennessy, B., Walshe, J., Parraga, K. Amillano, Ribi, K., Bernhard, J., Murillo, S. Morales, Pagani, O., Barbeaux, A., Borstnar, S., Rabaglio-Poretti, M., Maibach, R., Regan, M.M., Jerusalem, G.
Publikováno v:
In Annals of Oncology March 2018 29(3):661-668
Autor:
Curigliano, G *, †, Burstein, H.J. †, Winer, E.P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M.M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S.Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D.F., Huang, C.-S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K.C., Pagani, O., Partridge, A.H., Pritchard, K., Ro, J., Rutgers, E.J.T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T.J., Xu, B.
Publikováno v:
In Annals of Oncology August 2017 28(8):1700-1712